Published in Carcinogenesis on October 01, 2012
Markers of resistance to anti-EGFR therapy in colorectal cancer. J Gastrointest Oncol (2013) 1.01
Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res (2014) 0.97
Mouse models for colorectal cancer. Am J Cancer Res (2013) 0.91
Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med (2016) 0.90
Biology of colorectal cancer. Ecancermedicalscience (2015) 0.90
Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer. Nutr Cancer (2013) 0.89
Screening of potential diagnostic markers and therapeutic targets against colorectal cancer. Onco Targets Ther (2015) 0.88
Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? Biomed Res Int (2013) 0.87
Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population. PLoS One (2013) 0.86
MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9. Int J Clin Exp Pathol (2015) 0.82
The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms. Cancer Manag Res (2012) 0.81
A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer. Carcinogenesis (2014) 0.81
Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer. Aliment Pharmacol Ther (2014) 0.81
Genes, environment and gene expression in colon tissue: a pathway approach to determining functionality. Int J Mol Epidemiol Genet (2016) 0.78
Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes. Am J Hum Genet (2016) 0.77
MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients. BMC Genet (2016) 0.76
MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study. Nutr Cancer (2015) 0.76
DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer. Oncotarget (2017) 0.75
Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin. PeerJ (2016) 0.75
Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer. PLoS One (2017) 0.75
The exploration of network motifs as potential drug targets from post-translational regulatory networks. Sci Rep (2016) 0.75
Lovastatin exerts protective effects on endothelial cells via upregulation of PTK2B. Exp Ther Med (2016) 0.75
Dual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancer. Am J Cancer Res (2016) 0.75
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective. Curr Colorectal Cancer Rep (2016) 0.75
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet (2004) 14.76
Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) (2005) 9.85
MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52
Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst (2000) 4.39
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol (2000) 4.16
Energy balance and colon cancer--beyond physical activity. Cancer Res (1997) 3.11
Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev (2000) 3.05
MAP kinase pathways. J Cell Sci (2005) 3.04
MAP kinases and the control of nuclear events. Oncogene (2007) 2.74
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer (2008) 2.68
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem (2002) 2.45
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36
Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol (1994) 2.28
Physical activity and colorectal cancer. Am J Epidemiol (2003) 2.04
A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum (2009) 1.85
Ras target proteins in eukaryotic cells. FASEB J (1995) 1.77
Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer (2003) 1.55
Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer (2002) 1.46
NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene (2001) 1.28
Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int J Cancer (1997) 1.20
Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life (2006) 1.15
JNK regulation of oncogenesis. Mol Cells (2006) 1.12
Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. Carcinogenesis (2010) 1.08
MAP Kinases and Prostate Cancer. J Signal Transduct (2011) 1.06
Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig Dis Sci (1998) 1.04
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36
A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum (2009) 1.85
APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res (2007) 1.54
MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer (2010) 1.51
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis (2012) 1.40
Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.37
IL6 genotypes and colon and rectal cancer. Cancer Causes Control (2007) 1.36
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis (2007) 1.28
Microsatellite instability and survival in rectal cancer. Cancer Causes Control (2009) 1.24
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis (2010) 1.19
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res (2008) 1.18
Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer (2009) 1.17
Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res (2010) 1.17
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study. Genes Chromosomes Cancer (2013) 1.16
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog (2011) 1.16
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer (2011) 1.12
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway. Carcinogenesis (2010) 1.11
The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer (2008) 1.10
MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis (2016) 1.08
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis (2011) 1.05
CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.04
Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer. Mutat Res (2010) 1.04
Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer (2008) 1.04
Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer (2009) 1.03
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer (2010) 1.02
Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat (2007) 1.00
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol (2006) 1.00
Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer (2011) 0.99
Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor. BMC Med Genet (2010) 0.99
Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes. Mutat Res (2012) 0.99
Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res Treat (2011) 0.98
Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer (2006) 0.97
Genetic admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study? Cancer Epidemiol Biomarkers Prev (2007) 0.97
VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival. Mol Carcinog (2013) 0.97
Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One (2013) 0.97
Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer (2009) 0.97
Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control (2007) 0.95
Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat (2012) 0.95
Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control (2010) 0.94
Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat (2013) 0.93
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat (2011) 0.92
Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer (2011) 0.92
Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Int J Cancer (2013) 0.92
Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study. Int J Mol Epidemiol Genet (2012) 0.91
Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. J Rheumatol (2013) 0.90
Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer. Nutr Cancer (2013) 0.89
Variation in the CYP19A1 gene and risk of colon and rectal cancer. Cancer Causes Control (2011) 0.89
Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int J Cancer (2012) 0.88
Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer (2011) 0.88
TERT's role in colorectal carcinogenesis. Mol Carcinog (2012) 0.86
Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum (2012) 0.86
Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. Nutr Cancer (2010) 0.86
The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study. Cancer Causes Control (2013) 0.86
Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer. PLoS One (2012) 0.86
PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr (2012) 0.85
Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet (2010) 0.85
Tumor necrosis factor-related genes and colon and rectal cancer. Int J Mol Epidemiol Genet (2011) 0.85
Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Mutat Res (2006) 0.84
SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study. PLoS One (2013) 0.84
Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Obesity (Silver Spring) (2008) 0.84
Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat (2014) 0.83
MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog (2009) 0.82
Alcohol consumption and rectal tumor mutations and epigenetic changes. Dis Colon Rectum (2010) 0.82
Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study. Int J Mol Epidemiol Genet (2013) 0.81
Leptin and colorectal cancer: an undefined link. Nat Clin Pract Gastroenterol Hepatol (2007) 0.81